-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – 9MW-0211 in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - 9MW-0211 in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.9MW-0211 in Wet (Neovascular / Exudative) Macular DegenerationDrug Details:9MW-0211...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ALKS-2680 in Narcolepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ALKS-2680 in Narcolepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ALKS-2680 in Narcolepsy Drug Details: ALKS-2680 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FF-10502 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FF-10502 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.FF-10502 in Solid Tumor Drug Details:FF-10502 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Paclitaxel Albumin Bound in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel Albumin Bound in Gastric Cancer Drug Details: Paclitaxel (Abraxane, Abraxus ABI-007) is a taxane...
-
Product Insights
Hematological Disorders Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hematological Disorders Pipeline Market Report Overview The hematological disorders pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Hemostasis Tests ·       Coagulation Analyzers ·       Special Coagulation Tests ·       Hematology Tests ·       General Coagulation Tests Key...
-
Product Insights
Auto-Immune Diseases Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Auto-immune diseases Pipeline Market Report Overview Auto-immune diseases are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample. The auto-immune diseases pipeline market research report provides a comprehensive understanding of the pipeline products and their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories ·       The...
-
Product Insights
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline Market Report Overview Inflammatory Disease Markers are antigens/antibodies that detect specific antigens/antibodies produced by bone, cartilage, or any other inflammatory disease activity. The Inflammatory Disease Markers pipeline market research report provides comprehensive information about the inflammatory disease markers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP) Analyzer Tests ·       C-Reactive Protein (CRP)...
-
Thematic Analysis
Artificial Intelligence – Executive Briefing (Second Edition) – Thematic Intelligence
The additional benefits and features of the second edition include the following: Update on the latest trends in AI such as constitutional AI, dynalang, and AI TRiSM. Review recent AI chip developments, both technological and geopolitical. Analysis of emerging delivery models, with considerations on domain-specific training and data sensitivity. Regulatory update with a focus on the EU AI Act. Updated use cases and company profiles. How is the ‘AI Executive Briefing - Second Edition’ report different from other reports in the...
-
Thematic Analysis
Artificial Intelligence (AI) in Travel and Tourism – Thematic Intelligence
Explore trends and insights from the following data in our ‘Artificial Intelligence (AI) in Travel and Tourism’ thematic report: This report provides an overview of the AI theme. It provides a detailed value chain analysis, which comprises four segments: human AI interaction, decision-making AI, motion, and creation. Leading and challenging vendors are identified across both segments. The report identifies travel and tourism challenges, such as ESG, operational efficiency, and the COVID-19 hangover, and an impact assessment of AI on the...